Donor-Derived CD19 CAR-T Cells

CD19-targeted chimeric antigen receptor T cells · Zhejiang University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Donor-Derived CD19 CAR-T Cells, covering 2025-01-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic Leukemia [EARLY_Phase 1]